Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,029,409.2290
3,218,415.2290
3,745,798.7760
4,106,578.6190
3,974,364.5480
Cost of Revenue
851,338.3970
993,063.3970
1,209,901.2160
1,171,788.5790
925,529.5410
Gross Profit
2,178,070.8320
2,225,351.8320
2,535,897.5600
2,934,790.0400
3,048,835.0070
Operating Expense
1,123,205.6700
1,468,126.6700
1,798,107.6660
1,784,315.8460
1,328,741.9200
Operating Income
1,054,865.1620
757,225.1620
737,789.8940
1,150,474.1940
1,720,093.0870
Other Income Expense
627,448.8270
713,150.8270
300,931.3800
490,806.6800
469,022.3830
Pretax Income
1,682,313.9890
1,470,375.9890
1,038,721.2740
1,641,280.8740
2,189,115.4700
Tax Provision
366,878.2000
322,531.2000
238,502.1970
354,349.1340
436,392.6190
Net Income Common Stockholders
1,315,427.4270
1,147,837.4270
800,210.6720
1,286,920.0540
1,752,710.0760
Diluted NI Available to Com Stockholders
1,315,427.4270
1,147,837.4270
800,210.6720
1,286,920.0540
1,752,710.0760
Basic EPS
0.20
0.18
0.13
0.21
0.28
Diluted EPS
0.20
0.18
0.13
0.21
0.28
Basic Average Shares
6,229,328.6900
6,229,328.6900
6,229,328.6900
6,229,328.6900
6,229,331.0180
Diluted Average Shares
6,229,328.6900
6,229,328.6900
6,229,328.6900
6,229,328.6900
6,229,331.0180
Total Expenses
1,974,544.0670
2,461,190.0670
3,008,008.8820
2,956,104.4250
2,254,271.4610
Net Income from Continuing & Discontinued Operation
1,315,427.4270
1,147,837.4270
800,210.6720
1,286,920.0540
1,752,710.0760
Normalized Income
1,205,092.5063
994,218.8792
940,357.3426
1,286,920.0540
1,752,710.0760
EBIT
1,054,865.1620
757,225.1620
737,789.8940
1,150,474.1940
1,720,093.0870
EBITDA
1,083,781.5300
785,330.5300
765,910.4220
1,179,196.6490
1,745,378.5130
Reconciled Cost of Revenue
851,338.3970
993,063.3970
1,209,901.2160
1,171,788.5790
925,529.5410
Reconciled Depreciation
28,916.3680
28,105.3680
28,120.5280
28,722.4550
25,285.4260
Net Income from Continuing Operation Net Minority Interest
1,315,427.4270
1,147,837.4270
800,210.6720
1,286,920.0540
1,752,710.0760
Total Unusual Items Excluding Goodwill
141,107.5950
196,783.5950
-181,916.8430
--
--
Total Unusual Items
141,107.5950
196,783.5950
-181,916.8430
--
--
Normalized EBITDA
942,673.9350
588,546.9350
947,827.2650
1,179,196.6490
1,745,378.5130
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
30,772.6743
43,165.0472
-41,770.1724
0
0
12/31/2022 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade